The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis

HM Earl; L Hiller; JA Dunn; Sarah Bathers; RJ Grieve; David Spooner; RK Agrawal; L Foster; C Twelves; CJ Poole

doi:10.1200/jco.2007.25.18_suppl.534

The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis

HM Earl, L Hiller, JA Dunn, Sarah Bathers, RJ Grieve, David Spooner, RK Agrawal, L Foster, C Twelves, CJ Poole

Cancer and Genomic Sciences

Research output: Contribution to journal › Abstract

Original language	English
Article number	534
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	25
Issue number	18 suppl
DOIs	https://doi.org/10.1200/jco.2007.25.18_suppl.534
Publication status	Published - 20 Jun 2007
Event	American Society of Clinical Oncology (ASCO) 43rd Annual Meeting - Chicago, United States Duration: 1 Jun 2007 → 5 Jun 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.2007.25.18_suppl.534Licence: None: All rights reserved

Cite this

Earl, HM., Hiller, L., Dunn, JA., Bathers, S., Grieve, RJ., Spooner, D., Agrawal, RK., Foster, L., Twelves, C., & Poole, CJ. (2007). The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis. Journal of Clinical Oncology , 25(18 suppl), Article 534. https://doi.org/10.1200/jco.2007.25.18_suppl.534

@article{6f8c0dfac2684ad0a4281b48b14371ea,

title = "The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis",

author = "HM Earl and L Hiller and JA Dunn and Sarah Bathers and RJ Grieve and David Spooner and RK Agrawal and L Foster and C Twelves and CJ Poole",

year = "2007",

month = jun,

day = "20",

doi = "10.1200/jco.2007.25.18_suppl.534",

language = "English",

volume = "25",

journal = "Journal of Clinical Oncology ",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "18 suppl",

note = "American Society of Clinical Oncology (ASCO) 43rd Annual Meeting, ASCO 2007 ; Conference date: 01-06-2007 Through 05-06-2007",

}

Earl, HM, Hiller, L, Dunn, JA, Bathers, S, Grieve, RJ, Spooner, D, Agrawal, RK, Foster, L, Twelves, C & Poole, CJ 2007, 'The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis', Journal of Clinical Oncology , vol. 25, no. 18 suppl, 534. https://doi.org/10.1200/jco.2007.25.18_suppl.534

TY - JOUR

T1 - The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials

T2 - American Society of Clinical Oncology (ASCO) 43rd Annual Meeting

AU - Earl, HM

AU - Hiller, L

AU - Dunn, JA

AU - Bathers, Sarah

AU - Grieve, RJ

AU - Spooner, David

AU - Agrawal, RK

AU - Foster, L

AU - Twelves, C

AU - Poole, CJ

PY - 2007/6/20

Y1 - 2007/6/20

U2 - 10.1200/jco.2007.25.18_suppl.534

DO - 10.1200/jco.2007.25.18_suppl.534

M3 - Abstract

SN - 0732-183X

VL - 25

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18 suppl

M1 - 534

Y2 - 1 June 2007 through 5 June 2007

ER -